Dermatofibroma overview: Difference between revisions
Homa Najafi (talk | contribs) (→Causes) |
Homa Najafi (talk | contribs) No edit summary |
||
Line 15: | Line 15: | ||
The [[causes]] of Dermatofibroma has not been identified. | The [[causes]] of Dermatofibroma has not been identified. | ||
==Differentiating | ==Differentiating Dermatofibroma from Other Diseases== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== |
Revision as of 18:34, 27 June 2019
Dermatofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Dermatofibroma overview On the Web |
American Roentgen Ray Society Images of Dermatofibroma overview |
Risk calculators and risk factors for Dermatofibroma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
The causes of Dermatofibroma has not been identified.
Differentiating Dermatofibroma from Other Diseases
Epidemiology and Demographics
Dermatofibroma is a common benign skin lesion that is seen in almost 3000 dermatophatology laboratory specimens per 100,000 ones. As most of patients with Dermatofibroma are asymptomatic, the worldwide incidence of Dermatofibroma is unknown. Patients of all age groups may develop Dermatofibroma. Although, it is more occurred in 20s to 40s ages. There is no racial predilection to dermatofibroma. Female are more commonly affected by Dermatofibroma than male. The female to male ratio is approximately 2 to 1.
Risk Factors
There are no established risk factors for Dermatofibroma. Although, It is believed that minor trauma or a low-grade benign neoplasm can have role.